{"id":"W4408121967","doi":"10.2340/actadv.v105.42572","title":"Real-world Drug Survival of Biosimilar SB5 vs GP2017 Following a Mandatory Non-medical Switch from Adalimumab Originator for Psoriasis: A Nationwide Cohort Study","year":2025,"lang":"en","type":"article","venue":"Acta Dermato Venereologica","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Janssen Pharmaceuticals; Sanofi Genzyme; LEO Pharma; Bausch Health; Novo Nordisk; Galderma; Eli Lilly and Company; Bristol-Myers Squibb; Ortho Dermatologics; Cilag; Mylan; UCB Pharma; Kongelig Hofbuntmager Aage Bangs Fond; Regeneron Pharmaceuticals; Simon Spies Fonden; Les Laboratories Pierre Fabre; Celgene; Sanofi; Pfizer; Samsung; Galápagos; National Psoriasis Foundation; Amgen","keywords":"Medicine; Biosimilar; Adalimumab; Psoriasis; Cohort; Cohort study; Drug; Family medicine; Internal medicine; Pharmacology; Dermatology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002471528,0.0002934128,0.0005259326,0.0004606087,0.0003391195,0.000962977,0.0003737231,0.0006843859,0.001564144],"category_scores_gemma":[0.004482287,0.0002567676,0.001279792,0.0006760184,0.0002521547,0.0007730442,0.0005223787,0.0009912178,0.0003201905],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007837206,"about_ca_system_score_gemma":0.0005353747,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004306939,"about_ca_topic_score_gemma":0.003868404,"domain_scores_codex":[0.9986094,0.0004737521,0.000119269,0.0004084378,0.0001925239,0.0001965967],"domain_scores_gemma":[0.9956637,0.0009805826,0.002014207,0.0005597866,0.0003307986,0.0004509118],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.008580679,0.0004066752,0.9846349,0.00003213587,0.0006879659,0.0001366147,0.0001881562,0.0002604718,0.0006020223,0.00003869153,0.0003231755,0.004108535],"study_design_scores_gemma":[0.0002979336,0.003030574,0.9936744,0.00001402033,0.0005380424,0.0003425473,0.0002662123,0.001073338,0.0002473391,0.00004545759,0.0004470688,0.00002322622],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9995059,0.00008195485,0.00003621465,0.0000175508,0.000003647118,0.000006061577,0.0002544698,0.000001068588,0.00009310404],"genre_scores_gemma":[0.998928,0.00006993167,0.00003885281,0.00002850753,0.00001071725,0.000009128044,0.0008165481,0.000001657318,0.00009671402],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004306939,"threshold_uncertainty_score":0.01307082,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01488718902075747,"score_gpt":0.3182873033963715,"score_spread":0.303400114375614,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}